+ Tissue Fragment Injection System Emma Weinberger Ashley Quinn - - PowerPoint PPT Presentation

tissue fragment injection system emma weinberger ashley
SMART_READER_LITE
LIVE PREVIEW

+ Tissue Fragment Injection System Emma Weinberger Ashley Quinn - - PowerPoint PPT Presentation

+ Tissue Fragment Injection System Emma Weinberger Ashley Quinn Andrew Osterbauer JD Dorrance Octotober 21 st , 2011 + Points of Interest Client Information Final Design Problem Statement Future Work Background: Vx-2


slide-1
SLIDE 1

+

Tissue Fragment Injection System

Emma Weinberger Ashley Quinn Andrew Osterbauer JD Dorrance Octotober 21st, 2011

slide-2
SLIDE 2

+ Points of Interest

 Client Information  Problem Statement  Background: Vx-2  Current Methods: Surgical &

Percutaneous

 Design Criteria  Design Alternatives  Design Matrix  Final Design  Future Work  Conclusions  Questions

slide-3
SLIDE 3

+ Client Information

 Dr. Chris Brace  UW-Madison, Department of Radiology and Biomedical

Engineering

slide-4
SLIDE 4

+ Problem Statement

 Injection of Vx-2 carcinoma tumor cells in rabbit

livers

 Percutaneous less invasive than surgical  Limitations

 Suturing  Unwanted seeding  Backflow

 Eliminate limitations and lower technical skill

required

slide-5
SLIDE 5

+ Vx-2 Carcinoma Tumor Model

 Liver is most common

site for metastases

 Used in rabbits to study

liver cancer growth and develop treatments

 Similar characteristics

to human liver tumors

Luo et al

slide-6
SLIDE 6

+ Surgical Method

 Most common implantation method  Advantages

 Easy access to implantation site  Accurate cell placement  Minimal unwanted seeding in abdominal cavity

 Limitations include

 Long recovery time  Anesthetic complications  Length of procedure

 Dr. Brace’s current protocol is surgical

slide-7
SLIDE 7

+ Existing Percutaneous Method

Lee K-H et al  16-gauge needle

with a 14-gauge sheath

 Wire used to push

  • ut tumor cells

 Guided by ultra

sound imaging

slide-8
SLIDE 8

+ Design Criteria

 Seed tumor cells to the liver  Prevent unwanted tumor cell seeding  Decrease procedure time  Decrease technical skill  Biocompatible materials  18-gauge needle  5 cm insertion depth  Ergonomics

slide-9
SLIDE 9

+ Design Alternatives: Cellular Delivery Mechanism (CDM)

 Mechanical release  Uses two coaxial needles

 20-gauge and 18-gauge

 The 20-gauge has a specialized end  Cells directly loaded into compartment Mechanical Compartment 20G Needle

slide-10
SLIDE 10

+ Design Alternatives: PLGA Capsule

 Polylactic-co-

glycolic acid

 Biodegradable  Biocompatible  Mechanical

flexibility

 Dye-casting PLGA PLGA Tissue Fragment 10.1 mm 1.0 mm 12 mm 1.0 mm

slide-11
SLIDE 11

+ PLGA Capsule Cont.

 Biopsy needle  Tissue fragment notch  Retractable sheath 20mm 18-gague

slide-12
SLIDE 12

+ Design Alternatives: PLGA Covering with N-IPAAm Plug

 3 Needles

 18-gauge guide needle  Two 20-gauge needles

 1st: PLGA needle tip & cells  2nd: N-IPAAm

 Uses cell suspension PLGA Tip 20G Needle

slide-13
SLIDE 13

+ Design Matrix

Criteria Weight Value PLGA Capsule PLGA covering and N-IPAAm Plug CMD

Cost

10 6 5 7

Ease of use

20 15 12 12

Bio compatibility

20 10 8 15

Ergonomics

10 7 7 7

Reliability

30 18 22 6

Ease of production

10 8 6 4

Total

100 64 60 51

slide-14
SLIDE 14

+

PLGA PLGA Tissue Fragment

Final Design: PLGA Capsule

slide-15
SLIDE 15

+ Future Work

 Testing with PLGA  Testing with biopsy needle  Method of PLGA encapsulation

 “Sandwich” between two sheets  Encapsulate in pellet form

 RARC Certification

slide-16
SLIDE 16

+ Conclusions

 Decreased technical skill required  Procedure time reduced  Minimal unwanted seeding  Minimal backflow of cells

slide-17
SLIDE 17

+ Acknowledgements

 Dr. Chris Brace - Client  Dr. Randolph Ashton - Advisor

slide-18
SLIDE 18

+ References

 Brace, Chris. Person interview. September 9, 2011.  Georges et al. Two Shope papillomavirus-associated VX-2 carcinoma

cell lines with different levels of keratinocyte differentiation and

  • transplantability. Journal of Virology vol. 55:346-350, July 1985.

 Lee K-H et al. Percutaneous US-guided implantation of vx-2 carcinoma

into rabbit liver: A comparison with open surgical method. J Surg Res 155:95-99, 2009.

 Moore DH, Stone RS, Shope RE, et al. Ultrastructure and site formation of

rabbit papilloma virus. Proc Soc Exp Biol Med Jul;1959 101:575. [PubMed: 13675323]

 Luo et al. Role of sonography for implantationand sequential evaluation

  • f a VX2 rabbit liver tumor model. J Ultrasound Med 2010; 29:51–60.
slide-19
SLIDE 19

+